Join
Live feed
·
PRReleasevia Quantisnow
Auris Medical Holding Ltd. logo

Auris Medical Reaches Midpoint for Enrollment in Part B of AM-125 Phase 2 TRAVERS Trial in Acute Peripheral Vertigo

ByQuantisnow·Wall Street's wire, on your screen.
EARS· Auris Medical Holding Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EARS (Auris Medical Holding Ltd.) and more on Quantisnow.